Clinical Trial Update: RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides [NA]

View source ↗

Summary

This completed trial compared infliximab versus rituximab in systemic necrotizing vasculitides, including granulomatosis with polyangiitis, eosinophilic granulo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Granulomatosis with Polyangiitis
• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Drugs mentioned

• Infliximab (infliximab)
• Rituximab (rituximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Wegener's Granulomatosis, Churg-Strauss Syndrome | NA | Status: COMPLETED